Skip to content
Close
SEARCH
CONTACT US
CONTACT US

OUR SERVICES

We take a personalized and integrated approach to help our clients position their pipelines and companies for success offering a full range of development and commercialization services.

VIEW ALL SERVICES
PHASES
DISCOVERY
Uncover breakthrough
innovations during the drug
discovery phase.
CLINICAL DEVELOPMENT
Advance through clinical
development and health
authority review with confidence.
ALL STAGES
Benefit from our expertise
across all phases
of drug development.
PRECLINICAL
Navigate the critical
preclinical testing phase
with expert guidance.
COMMERCIALIZATION
Successfully bring your
product to market with
our commercialization support.
ALL SERVICES
Access comprehensive
services for every stage
of product development.

ABOUT US

We are Halloran, a life science consulting firm, partnering to enrich your product development and business growth. We propel your organization further; positively impacting the health and wellbeing of patients around the world.

LEARN MORE ABOUT US
EXPERTISE WITH PERSONALITY
OUR FOUNDER
Discover the visionary
leader driving Halloran's
success and innovation.
STRATEGIC PARTNERS
Meet our trusted
strategic partners who
enhance our capabilities.
WHY HALLORAN?
Explore the unique reasons
why clients choose
Halloran for their needs.
OUR TEAM
Get to know the dedicated
professionals who make
up the Halloran team.
CAREERS
Join our dynamic team
and advance your
career with Halloran.
LEARN MORE
Find out more about
Halloran's comprehensive
services and expertise.
hcg-service-hero-1

Indication Assessment & Prioritization

 

 

PORTFOLIO AND ASSET OPTIMIZATION

Indication Assessment and Prioritization (IAP) forms the cornerstone of strategic evaluation for identified indications, leveraging key parameters to determine their potential value. The selection of an indication significantly impacts an asset's value, influencing factors such as timeline, costs, risks, and commercial potential. Aligning the chosen indication with the overarching strategy is essential for maximizing asset value.

For instance, if the objective is rapid revenue generation through out-licensing post proof of principle (PoP) demonstration, selecting an indication with robust scientific backing and expedited Phase 1 surrogate endpoints is ideal. Conversely, if the goal is to expedite market entry, prioritizing indications with high commercial potential and shorter clinical timelines is paramount.

IAP provides strategic direction for internal stakeholders and serves as a guide for potential partners externally. This dynamic framework allows for continuous adaptation as new information surfaces, facilitating ongoing evaluation and scoring adjustments.

OUR APPROACH

We collaborate closely with client stakeholders to grasp strategic objectives and establish critical considerations for indication assessment and evaluation. These considerations are tailored based on factors such as company stage (early or late discovery, early development), funding status (pre-seed, Series A or B), and whether the client operates as a platform or single asset company.

Utilizing a multi-attribute methodology and model, we craft a comprehensive framework encompassing key attributes essential for indication assessment and prioritization. These attributes are segmented into three primary areas:

  • Technical Feasibility
  • Commercial Opportunity
  • Time and Risk to PoP

We construct a conceptual framework that integrates elements of risk, cost, and commercial opportunity, presenting it as a heatmap for a holistic overview. Additionally, a combined score and ranked order of indications offer clarity on the drivers behind their value, addressing the 'why' for each prioritization.

We have a passion for life sciences, and we have a purpose to be your trusted partner. By partnering with us, we leverage our deep industry expertise and innovative strategies to help your company move through the complex clinical, regulatory, and quality journey. Our proven track record in navigating complex ecosystem challenges and accelerating development timelines means you can focus on groundbreaking science while we handle the rest. Together, we will maximize your company's potential, driving both clinical and commercial success.

hcg-form-microscope-background-2
REACH YOUR MILESTONES

LET’S GET TO WORK

Halloran has the team and the experience to help you in your lifecycle journey. Contact us today to learn more about how we can help you!